Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Life Sciences and Osaka University Team Up

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Top four graduate students to be hosted at GE Healthcare Life Science’s Uppsala site.

GE Healthcare Life Sciences has announced a joint program with Osaka University to offer students access to GE Healthcare’s cutting-edge expertise in training and technologies for biopharmaceutical research and manufacturing, to help support future growth of the sector in Japan.

The program, Interdisciplinary Program for Biomedical Sciences (IPBS), is Osaka University’s government-funded commitment to graduate education, which aligns with GE Healthcare Japan’s “Life Sciences Academy,” a GE Healthcare initiative launched in April 2013 with the objective of supporting the development of life sciences researchers in Japan.

Of the 14 IPBS graduate students, four will visit GE Healthcare Life Science’s Uppsala site for three weeks from 19 August to 6 September 2013.

While at GE Healthcare in Uppsala, the Osaka University students will experience day-to-day life in an R&D laboratory, closely working with GE Healthcare scientists and engineers.

The students will receive comprehensive training in GE Healthcare’s advanced bioprocessing technologies and gain first-hand experience of protein interaction analysis and laboratory-scale protein purification using GE Healthcare instruments including Biacore™ and MicroCal™ systems for label-free analyses and ÄKTA™ pure chromatography systems.

Anders Fält, Head of R&D, Bio-Analysis Systems, GE Healthcare Life Sciences, commented, “This joint program with Osaka University is a great way to share our knowledge and expertise, as well as encourage and inspire the life sciences researchers and manufacturing professionals of tomorrow. Specifically, we’re providing an opportunity for students from one of the leading Japanese universities to be introduced to the latest technologies and workflows from GE Healthcare, taking them closer to becoming tomorrow’s leading life scientists.”

Kiyoshi Takeda, MD, PhD, the coordinator of the Interdisciplinary Program for Biomedical Sciences (IPBS) at Osaka University, commented, “Our program seeks to educate young life scientists so that they will play an active role at the front lines of global-scale research collaborations whether it would be in the industry, academic or government sectors, during their careers. We strongly believe our students will gain valuable experience from the internship at the GE Healthcare Life Sciences R&D Center in Uppsala. Our joint program with GE Healthcare is an excellent example of cooperation between university and industry, a collaboration that has not been possible in the traditional Japanese education system. We hope such a collaborative educational program will strengthen the relations between academia and industry for the coming generations, leading the way to advanced treatment research for intractable diseases.”

During their visit, on which they will be joined by their Professor, Masayuki Miyasaka, a world-renowned immunologist, the students will also meet scientists at the SciLifeLab at the Karolinska Institutet, one of the largest medical universities in Europe.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences to Open Biopharmaceutical Technology and Training Laboratory in Turkey
Supports Turkey’s ambitions to expand domestic biopharmaceutical industry. Laboratory will be a key component of GE’s new Innovation Center in Istanbul.
Friday, November 14, 2014
GE Healthcare Life Sciences Named as Finalist for Four Bioprocess Industry Awards
Awards celebrate and recognize the outstanding people, organizations and technologies.
Saturday, October 04, 2014
GE Healthcare Life Sciences to Create New US Headquarters
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.
Wednesday, August 20, 2014
GE Healthcare Appoints Emmanuel Ligner as General Manager
Emmanuel will oversee all worldwide commercial activities of Company's rapidly growing BioProcess business.
Friday, April 11, 2014
GE Healthcare to Build KUBio Factory for JHL Biotech in China
New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia.
Thursday, September 26, 2013
GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.
Acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of recombinant proteins, antibodies and vaccines.
Tuesday, May 15, 2012
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!